Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 8,220 Rapport Therapeutics, Inc. shares (Form 4)

Traded Jun 29, 2026 · Filed Jul 1, 2026

On Jun 29, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 8,220 Rapport Therapeutics, Inc. shares at an average US$39.83 for US$327K under a trading plan, leaving 548,027 shares. Filed Jul 1, 2026 (Form 4).

Sold
8,220 shares
Price
US$39.83 average (US$39.77 to US$40.34)
Value
US$327K
Holding after
548,027 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 29, 2026Common StockSale7,344US$39.77548,903Direct
Jun 29, 2026Common StockSale876US$40.34548,027Direct

Source

View original at SEC

Related